Literature DB >> 6790560

Calcium and calcium-antagonistic effects on prolactin and growth hormone responses to thyrotropin-releasing hormone and L-dopa in man.

S Röjdmark, D E Andersson, L Sundblad.   

Abstract

The significance of calcium for the responsiveness of human lactotrophs and somatotrophs to iv TRH and oral L-dopa was investigated in 11 young healthy women. Both TRH and L-dopa were administered on three different background infusions: 1) saline, 2) verapamil, and 3) calcium. Twenty-five micrograms of TRH raised the PRL level from 15.1 +/- 2.3 to 76.9 +/- 8.8 ng/ml in 15 min (P less than 0.001). Calcium infusion blunted this PRL response by 33 +/- 8% (P less than 0.02), whereas verapamil, known for its calcium-antagonistic properties, left in unaffected. Five hundred milligrams of L-dopa increased the GH level from 2.2 +/- 0.7 to 16.7 +/- 2.2 ng/ml in 60 min (P less than 0.002) and reduced the PRL level from 11.6 +/- 2.9 to 3.1 +/- 0.4 ng/ml in 150 min (P less than 0.05). Neither calcium nor verapamil influenced these GH and PRL responses significantly. These findings indicate that human somatotrophs may be less dependent than human lactotrophs on normocalcemia for adequate hormone secretion.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6790560     DOI: 10.1210/jcem-53-3-594

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  8 in total

Review 1.  Drug-induced changes in prolactin secretion. Clinical implications.

Authors:  K Hell; H Wernze
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 Nov-Dec

Review 2.  Thyrotropin releasing hormone. A review of the mechanisms of acute stimulation of pituitary hormone release.

Authors:  M C Gershengorn
Journal:  Mol Cell Biochem       Date:  1982-06-25       Impact factor: 3.396

3.  Serum prolactin during status epilepticus.

Authors:  T Tomson; U Lindbom; B Y Nilsson; E Svanborg; D E Andersson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-12       Impact factor: 10.154

4.  Lack of effect of moderate hypercalcemia on gonadotropin responsiveness to GnRH.

Authors:  S Röjdmark; A Carlsson
Journal:  J Endocrinol Invest       Date:  1987-04       Impact factor: 4.256

5.  Serum prolactin response to metoclopramide during status epilepticus.

Authors:  U Lindbom; T Tomson; B Y Nilsson; D E Andersson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-08       Impact factor: 10.154

6.  Effect of 1,25-dihydroxyvitamin D3 on plasma prolactin in patients with renal failure on regular dialysis treatment.

Authors:  D Verbeelen; L Vanhaelst; A C Van Steirteghem; J Sennesael
Journal:  J Endocrinol Invest       Date:  1983-10       Impact factor: 4.256

7.  Effect of chronic endogenous hypercalcemia on prolactin and thyrotropin responsiveness in man.

Authors:  S Röjdmark; E Edström; M Nordlund
Journal:  J Endocrinol Invest       Date:  1984-12       Impact factor: 4.256

8.  Effect of 1,25-dihydroxyvitamin D3 and nifedipine on prolactin release in normal man.

Authors:  D Verbeelen; L Vanhaelst; M Fuss; A C Van Steirteghem
Journal:  J Endocrinol Invest       Date:  1985-04       Impact factor: 4.256

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.